FT. LAUDERDALE, FL--(Marketwire - April 04, 2008) - OmniComm Systems, Inc. (OTCBB: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that OmniComm will partner with Logos Technologies and create an integrated solution with ALPHADAS®, the premier electronic data capture solution designed specifically for Phase I clinical trials. The combined technologies will be available for use by customers using the TrialMaster™, First in Functionality™, EDC solution.
